Course on the Methodology of Comprehensive Clinical Evaluation of Medicines in Beijing, China 2024

Uncategorized

At the invitation from the Beijing Children’s Hospital, Capital Medical University, HIPER – Centre for Health Intervention and Policy Evaluation Research and  HITAP, Thailand recently conducted the Third Training Course on the Methodology of Comprehensive Clinical Evaluation of Medicines in Beijing, China.
The hands-on training course was conducted over two days (20th – 21st September 2024) in Mandarin. Through the course, over 20 participants from various government, healthcare and private organizations were equipped with both theoretical knowledge and practical skills to perform Health Technology Assessments (HTA). The course covered techniques to construct deterministic Markov models as well as strategies to perform deterministic and probabilistic sensitivity analyses. In addition, participants were provided with an overview of the aspects of model validation, and key pointers on presenting economic evaluations in alignment with CHEERS and CNHDRC guidelines.
The course lecturers included A/Prof Hwee-Lin Wee, Asst Prof YI WANG, Dr Jing Lou, and Dr Sharon Tan, and the other course instructors included Prof Yot Teerawattananon, Prof Alec Morton, Mr Manit Sittimart, Ms Waranya Rattanavipapong, and Ms Nitichen Kittiratchakool.
On 22nd September 2024, the team from HIPER also participated in the Fourth Symposium on System Construction of National Medicine Evaluation in Belt and Road Countries. Prof Alec Morton shared on HTA of precision medicine, Prof Yot Teerawattananon presented on Developing HTA in Southeast Asia: Lessons for China, while Asst Prof Wang Yi presented on early HTA. Through the workshop and symposium, close international collaborations and partnerships between NUS and HTA partners in China have been forged.

新加坡国立大学苏瑞福公共卫生学院卫生干预和政策评估研究中心(HIPER)与泰国卫生干预和技术评估项目中心 (HITAP) 在首都医科大学附属北京儿童医院主办单位的邀请下,在北京进行了第三届药品临床综合评价方法学培训班。这两天的课程以中文授课。超过20位来自各政府单位,医药部门以及企业的嘉宾参加了这次的培训班,并从中了解了卫生经济学的原理和卫生技术评估(HTA)的方法和实践技巧。课程包括了建设确定性和概率性的马尔可夫模型,敏感性分析,模型验证和依照CHEERS 和CNHDRC指南呈现经济评价研究结果的方式。除此之外,HIPER 也在9月22日参与了第四届“一带一路”国家药品临床综合评价体系建设交流会。通过这次的会议和培训班,HIPER 和中国北京儿童医院及其他HTA机构建立了友好关系,促进了更密切的交流,也进一步拓展了国际合作。